Commission Implementing Regulation (EU) 2017/555 of 24 March 2017 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of several active substances listed in Part B of the Annex to Implementing Regulation (EU) No 686/2012 (AIR IV renewal programme) (Text with EEA relevance. )

• CELEX: Implementing Regulation (EU) 2017/555
• Articles: 3

Article 1

The Annex to Implementing Regulation (EU) No 540/2011 is amended in accordance with the Annex to this Regulation

Article 2

This Regulation shall enter into force on the third day following that of its publication in the Official Journal of the European Union .

Schedules & Appendices

ANNEX

ANNEX

Part A of the Annex to Implementing Regulation (EU) No 540/2011 is amended as follows:

(1)

in the sixth column, expiration of approval, of row 271, Bensulfuron, the date is replaced by ‘31 October 2022’;

(2)

in the sixth column, expiration of approval, of row 272, Sodium 5-nitroguaiacolate, the date is replaced by ‘31 October 2022’;

(3)

in the sixth column, expiration of approval, of row 273, Sodium o-nitrophenolate, the date is replaced by ‘31 October 2022’;

(4)

in the sixth column, expiration of approval, of row 274, Sodium p-nitrophenolate, the date is replaced by ‘31 October 2022’;

(5)

in the sixth column, expiration of approval, of row 275, Tebufenpyrad, the date is replaced by ‘31 October 2022’;

(6)

in the sixth column, expiration of approval, of row 276, Chlormequat, the date is replaced by ‘30 November 2021’;

(7)

in the sixth column, expiration of approval, of row 278, Propaquizafop, the date is replaced by ‘30 November 2021’;

(8)

in the sixth column, expiration of approval, of row 281, zeta-Cypermethrin, the date is replaced by ‘30 November 2021’;

(9)

in the sixth column, expiration of approval, of row 284, Dimethachlor, the date is replaced by ‘31 December 2021’;

(10)

in the sixth column, expiration of approval, of row 285, Etofenprox, the date is replaced by ‘31 December 2021’;

(11)

in the sixth column, expiration of approval, of row 287, Penconazole, the date is replaced by ‘31 December 2021’;

(12)

in the sixth column, expiration of approval, of row 288, Tri-allate, the date is replaced by ‘31 December 2021’;

(13)

in the sixth column, expiration of approval, of row 292, Sulphur, the date is replaced by ‘31 December 2020’;

(14)

in the sixth column, expiration of approval, of row 293, Tetraconazole, the date is replaced by ‘31 December 2021’;

(15)

in the sixth column, expiration of approval, of row 294, Paraffin oils, the date is replaced by ‘31 December 2020’;

(16)

in the sixth column, expiration of approval, of row 295, Paraffin oil, the date is replaced by ‘31 December 2020’;

(17)

in the sixth column, expiration of approval, of row 299, 2-phenylphenol (including its salts such as the sodium salt), the date is replaced by ‘31 December 2021’;

(18)

entry 279 is replaced by the following:

‘279

Quizalofop-P

Quizalofop-P-tefuryl

CAS No 119738-06-6

CIPAC No 641.226

(RS)-Tetrahydrofurfuryl (R)-2-[4-(6-chloroquinoxalin-2-yloxy)phenoxy]propionate

≥ 795 g/kg

1 December 2009

30 November 2019

PART A

Only uses as herbicide may be authorised.

PART B

For the implementation of the uniform principles as referred to in Article 29(6) of Regulation (EC) No 1107/2009, the conclusions of the review report on quizalofop-P, and in particular Appendices I and II thereof, as finalised in the Standing Committee on the Food Chain and Animal Health on 23 January 2009 shall be taken into account.

In this overall assessment Member States must pay particular attention to:

—

the specification of the technical material as commercially manufactured which must be confirmed and supported by appropriate analytical data. The test material used in the toxicity dossiers should be compared and verified against this specification of the technical material,

—

the operator and worker safety and ensure that conditions of use prescribe the application of adequate personal protective equipment,

—

the protection of non-target plants and ensure that conditions of authorisation include risk mitigation measures such as buffer zones, where appropriate.

Conditions of authorisation shall include risk mitigation measures, where appropriate.

The Member States concerned shall ensure that the notifier submits to the Commission further information on the risk to non-target arthropods.

They shall ensure that the notifier provides such information to the Commission by 30 November 2011.’

Quizalofop-P-ethyl

CAS No 100646-51-3

CIPAC No 641.202

ethyl (R)-2-[4-(6-chloroquinoxalin-2-yloxy)phenoxy]propionate

≥ 950 g/kg

1 December 2009

30 November 2021